
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
Authors' Affiliation: Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands
Requests for reprints: Giuseppe Giaccone, Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. Phone: 31-20-4444321; Fax: 31-20-4444079; E-mail: g.giaccone{at}vumc.nl.
Patterns of cell death have been divided into apoptosis, which is actively executed by specific proteases, the caspases, and accidental necrosis. However, there is now accumulating evidence indicating that cell death can occur in a programmed fashion but in complete absence and independent of caspase activation. Alternative models of programmed cell death (PCD) have therefore been proposed, including autophagy, paraptosis, mitotic catastrophe, and the descriptive model of apoptosis-like and necrosis-like PCD. Caspase-independent cell death pathways are important safeguard mechanisms to protect the organism against unwanted and potential harmful cells when caspase-mediated routes fail but can also be triggered in response to cytotoxic agents or other death stimuli. As in apoptosis, the mitochondrion can play a key role but also other organelles such as lysosomes and the endoplasmic reticulum have an important function in the release and activation of death factors such as cathepsins, calpains, and other proteases. Here we review the various models of PCD and their death pathways at molecular and organelle level and discuss the relevance of the growing knowledge of caspase-independent cell death pathways for cancer.
Key Words: apoptosis death pathway programmed cell death
This article has been cited by other articles:
![]() |
J. Shi, J. D. Orth, and T. Mitchison Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5 Cancer Res., May 1, 2008; 68(9): 3269 - 3276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuthanova, Z. Opatrny, and L. Fischer Is internucleosomal DNA fragmentation an indicator of programmed death in plant cells? J. Exp. Bot., May 1, 2008; 59(8): 2233 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kumar, K. G. Cordell, N. D'Silva, M. E. Prince, M. E. Adams, S. G. Fisher, G. T. Wolf, T. E. Carey, and C. R. Bradford Expression of p53 and Bcl-xL as Predictive Markers for Larynx Preservation in Advanced Laryngeal Cancer Arch Otolaryngol Head Neck Surg, April 1, 2008; 134(4): 363 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Wang, S.-L. Pan, Y.-C. Huang, J.-H. Guh, P.-C. Chiang, D.-Y. Huang, S.-C. Kuo, K.-H. Lee, and C.-M. Teng CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo Mol. Cancer Ther., February 1, 2008; 7(2): 350 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Kil, D. Cerna, W. E. Burgan, K. Beam, D. Carter, P. S. Steeg, P. J. Tofilon, and K. Camphausen In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide Clin. Cancer Res., February 1, 2008; 14(3): 931 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lechner, N. Malloth, T. Seppi, B. Beer, P. Jennings, and W. Pfaller IFN-{alpha} induces barrier destabilization and apoptosis in renal proximal tubular epithelium Am J Physiol Cell Physiol, January 1, 2008; 294(1): C153 - C160. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Garneau, L. Alvarez, M.-C. Paquin, C. Lussier, C. Rancourt, E. Tremblay, J.-F. Beaulieu, and N. Rivard Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G758 - G772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohshiro, S. K. Rayala, S. Kondo, A. Gaur, R. K. Vadlamudi, A. K. El-Naggar, and R. Kumar Identifying the Estrogen Receptor Coactivator PELP1 in Autophagosomes Cancer Res., September 1, 2007; 67(17): 8164 - 8171. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Lobascio, F G Klinger, M L Scaldaferri, D Farini, and M De Felici Analysis of programmed cell death in mouse fetal oocytes Reproduction, August 1, 2007; 134(2): 241 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E.W. Cohen A Disturbance in the Force Mitochondrial Mutations in Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., August 1, 2007; 13(15): 4317 - 4319. [Full Text] [PDF] |
||||
![]() |
S. Ohtani, A. Iwamaru, W. Deng, K. Ueda, G. Wu, G. Jayachandran, S. Kondo, E. N. Atkinson, J. D. Minna, J. A. Roth, et al. Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non-Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy Cancer Res., July 1, 2007; 67(13): 6293 - 6303. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Trincheri, G. Nicotra, C. Follo, R. Castino, and C. Isidoro Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D Carcinogenesis, May 1, 2007; 28(5): 922 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Viemann, K. Barczyk, T. Vogl, U. Fischer, C. Sunderkotter, K. Schulze-Osthoff, and J. Roth MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program Blood, March 15, 2007; 109(6): 2453 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Vega-Manriquez, Y. Lopez-Vidal, J. Moran, L. G. Adams, and J. A. Gutierrez-Pabello Apoptosis-Inducing Factor Participation in Bovine Macrophage Mycobacterium bovis-Induced Caspase-Independent Cell Death Infect. Immun., March 1, 2007; 75(3): 1223 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Kogan, M. Schlesinger, E. Priel, R. Rabinowitz, E. Berenshtein, M. Chevion, and R. Mechoulam HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor Mol. Cancer Ther., January 1, 2007; 6(1): 173 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Geer, R. Kiessling, V. Levitsky, and J. Levitskaya Cytotoxic T Lymphocytes Induce Caspase-Dependent and -Independent Cell Death in Neuroblastomas in a MHC-Nonrestricted Fashion J. Immunol., December 1, 2006; 177(11): 7540 - 7550. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Camby, M. Le Mercier, F. Lefranc, and R. Kiss Galectin-1: a small protein with major functions Glycobiology, November 1, 2006; 16(11): 137R - 157R. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Furth and E. D. Halama What Do Shifts in Indicators of Apoptosis Indicate about the Cancer Process? J. Nutr., October 1, 2006; 136(10): 2700S - 2703S. [Full Text] [PDF] |
||||
![]() |
N. Duerrschmidt, O. Zabirnyk, M. Nowicki, A. Ricken, F. A. Hmeidan, V. Blumenauer, J. Borlak, and K. Spanel-Borowski Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1-Mediated Autophagy in Human Granulosa Cells as an Alternative of Programmed Cell Death Endocrinology, August 1, 2006; 147(8): 3851 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Puthia, S. W. S. Sio, J. Lu, and K. S. W. Tan Blastocystis ratti Induces Contact-Independent Apoptosis, F-Actin Rearrangement, and Barrier Function Disruption in IEC-6 Cells Infect. Immun., July 1, 2006; 74(7): 4114 - 4123. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Taylor, S. C. McNeely, H. L. Miller, G. M. Lehmann, M. J. McCabe Jr., and J. C. States p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1 J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ouyang, Y.-C. Shen, L.-K. Yeh, W. Li, B. M. Coyle, C.-Y. Liu, and M. E. Fini Pax6 overexpression suppresses cell proliferation and retards the cell cycle in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2397 - 2407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Ricci and W.-X. Zong Chemotherapeutic approaches for targeting cell death pathways. Oncologist, April 1, 2006; 11(4): 342 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Huang, L. Lopez-Barcons, B. S. Freeze, A. B. Smith III, G. L. Goldberg, S. B. Horwitz, and H. M. McDaid Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice Clin. Cancer Res., January 1, 2006; 12(1): 298 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Shacka and K. A. Roth Cathepsin Deficiency as a Model for Neuronal Ceroid Lipofuscinoses Am. J. Pathol., December 1, 2005; 167(6): 1473 - 1476. [Full Text] [PDF] |
||||
![]() |
H. S. Floyd, C. L. Farnsworth, N. D. Kock, M. C. Mizesko, J. L. Little, S. T. Dance, J. Everitt, J. Tichelaar, J. A. Whitsett, and M. S. Miller Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model Carcinogenesis, December 1, 2005; 26(12): 2196 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Terman and U. T. Brunk Autophagy in cardiac myocyte homeostasis, aging, and pathology Cardiovasc Res, December 1, 2005; 68(3): 355 - 365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |